Personalized Stem Cells - FDA Approved Clinical Trials
  • Home
  • Patient
    • FAQ
  • Physician
  • Clinical Trials
    • Knee Osteoarthritis (fully enrolled)
    • COVID-19 Clinical Trials
    • Future Clinical Trials
  • About
    • Personalized Stem Cells
    • Leadership
    • Investors
  • Media
    • News
    • Blog
    • Videos
    • Facebook
  • Contact
  • 833-772-3557
Select Page

CoronaStem 1 Trial – Personalized Stem Cells Files for Expedited FDA Approval to Treat COVID-19 Patients

by Ashley | Apr 21, 2020 | COVID-19, FDA Approved Clinical Trial, Personalized Stem Cells, Press Release, Stem Cell Therapy

Personalized Stem Cells, Inc. (PSC) and its parent company, VetStem Biopharma, have filed an expedited review request for an Investigational New Drug (IND) application with the FDA for the treatment of COVID-19 patients with stem cells. The first trial is named...
Copyright © 2023. Personalized Stem Cells. All rights reserved. Privacy Policy
/* First CSS File */ var giftofspeed = document.createElement('link'); giftofspeed.rel = 'stylesheet'; giftofspeed.href = 'https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css'; giftofspeed.type = 'text/css'; var godefer = document.getElementsByTagName('link')[0]; godefer.parentNode.insertBefore(giftofspeed, godefer);